HMG-CoA Reductase Inhibitors (Statins) May Preserve Hepatic Function and Reduce Portal-Systemic Shunting in Compensated Advanced Chronic Liver Disease: Results From the SHUNT-V Study. [PDF]
Rahimi RS +10 more
europepmc +1 more source
Synthesis of Caged HMG-CoA Reductase Substrates for the Elucidation of Cellular Pathways. [PDF]
O'Connell RJ +6 more
europepmc +1 more source
Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase. [PDF]
Zaborowska-Mazurkiewicz M +2 more
europepmc +1 more source
Repurposing statins for the treatment of larval cestodiases: <i>in silico</i> evaluation of statin-HMG-CoA reductase interactions and assessment of statin effects on a cestode model. [PDF]
Monteiro Guedes M +8 more
europepmc +1 more source
miR-139-5p activates ferroptosis by inhibiting the expression of HMG-CoA reductase to inhibit the progression of glioma. [PDF]
You Z +9 more
europepmc +1 more source
Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor. [PDF]
Catalão CHR +9 more
europepmc +1 more source
Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis. [PDF]
Makhlouf HA +5 more
europepmc +1 more source
A novel approach to assessing the bioavailability of biopeptide inhibitor of HMG CoA reductase from germinated and ungerminated Kara Kratok (<i>Phaseolus lunatus</i> L.). [PDF]
Budiyanto C +3 more
europepmc +1 more source
Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients. [PDF]
Khaleqsefat E +4 more
europepmc +1 more source

